one qPCR assay instead of two or more
SARS CoV-2 + Alpha-Delta qPCR assay for screening and simultaneous VoC detection
Our new ALPHA-DELTA-Screening assays combines dual target SARS-CoV-2 detection with VoC determination of the two most relevant VoCs ALPHA and DELTA that make up > 99% of the strains in most countries of the world (see: https://covariants.org/per-country). The assay is based on a highly robust detection SARS-CoV-2 using the CDC / WHO recommended N-Gene assay and detects the Delta and Alpha strains via assays that are highly specific for mutations each strain.
Our ALPHA-DELTA Screening Assay combines:
-
Dual Target SARS-CoV-2 detection and simultaneous detection of the Alpha and Delta VoC
-
Screens for SARS-CoV-2 while simultaneously detects the two most relevant VoCs, Delta and Alpha which represent > 99% of samples in most countries in Europe and in USA.
-
The assay includes the WHO-recommended N1 gene in addition to highly robust detection assays for deletions present in the Alpha and in the Delta VoC.
-
Each positive sample is detected with two targets (dual target assay) required for a secure diagnostics
-
Sampling- or positive control is included for highly reliable assay conditions
Assay Design and Probes
Results from ABI-7500 -Other qPCR machines with channels for FAM, HEX, ROX and Cy5 can be used
Cat. Nr. 031522-ALPHA-DELTA; 96-10.000 reactions
Further Assay Combinations available at GenXPro
-
N-Gene, Delta and Lambda, internal Control
-
N-Gene, Delta and Mu, internal Control
Further mutation -specificqPCR assays avalable for SARS-CoV-2
-
P681R
-
L452R
-
K417N
Contact
For more information or to purchase the kit, please write us an e-mail (info@genxpro.de), or call us at (+49 69) 95739710 ).